Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

PIALOUX

Showing results (571-580 of 578) with videos related to

Pageof 58
Sort By:
You have reached the last page of results.This site can display upto 578 results.
Brain Communications|May 3, 2021
Cortical inflammation and brain signs of high-risk atherosclerosis in a non-human primate modelVanessa Di Cataldo, Justine Debatisse, Joao Piraquive, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|July 13, 2011
A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPEEmmanuelle Chaléat-Valayer, Bernard Parratte, Cyrille Colin, et al.
Plos One|January 26, 2019
Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort studySarah Shili-Masmoudi, Philippe Sogni, Victor de Ledinghen, et al.
The Journal of Infection|July 8, 2022
Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2Guillaume Martin-Blondel, Anne-Genevieve Marcelin, Cathia Soulié, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 31, 2022
Time to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated with sotrovimab or nirmatrelvirGuillaume Martin-Blondel, Anne-Geneviève Marcelin, Cathia Soulié, et al.
The New England Journal of Medicine|December 2, 2015
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 InfectionJean-Michel Molina, Catherine Capitant, Bruno Spire, et al.
Medicine|February 13, 2016
The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled TrialWarren Dinges, Pierre-Marie Girard, Daniel Podzamczer, et al.
Eclinicalmedicine|March 30, 2022
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study groupOlivier Hermine, Xavier Mariette, Raphael Porcher, et al.
Pageof 58

Showing results (571-580 of 578) with videos related to

Sort By:
Pageof 58
You have reached the last page of results.This site can display upto 578 results.
Brain Communications|May 3, 2021
Cortical inflammation and brain signs of high-risk atherosclerosis in a non-human primate modelVanessa Di Cataldo, Justine Debatisse, Joao Piraquive, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|July 13, 2011
A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPEEmmanuelle Chaléat-Valayer, Bernard Parratte, Cyrille Colin, et al.
Plos One|January 26, 2019
Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort studySarah Shili-Masmoudi, Philippe Sogni, Victor de Ledinghen, et al.
The Journal of Infection|July 8, 2022
Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2Guillaume Martin-Blondel, Anne-Genevieve Marcelin, Cathia Soulié, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 31, 2022
Time to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated with sotrovimab or nirmatrelvirGuillaume Martin-Blondel, Anne-Geneviève Marcelin, Cathia Soulié, et al.
The New England Journal of Medicine|December 2, 2015
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 InfectionJean-Michel Molina, Catherine Capitant, Bruno Spire, et al.
Medicine|February 13, 2016
The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled TrialWarren Dinges, Pierre-Marie Girard, Daniel Podzamczer, et al.
Eclinicalmedicine|March 30, 2022
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study groupOlivier Hermine, Xavier Mariette, Raphael Porcher, et al.
Pageof 58